JP2021525704A5 - - Google Patents

Info

Publication number
JP2021525704A5
JP2021525704A5 JP2020563751A JP2020563751A JP2021525704A5 JP 2021525704 A5 JP2021525704 A5 JP 2021525704A5 JP 2020563751 A JP2020563751 A JP 2020563751A JP 2020563751 A JP2020563751 A JP 2020563751A JP 2021525704 A5 JP2021525704 A5 JP 2021525704A5
Authority
JP
Japan
Prior art keywords
compound
composition according
approximately
plasma concentration
individual
Prior art date
Application number
JP2020563751A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019222764A5 (https=
JP2021525704A (ja
JP7519909B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/033727 external-priority patent/WO2019222764A1/en
Publication of JP2021525704A publication Critical patent/JP2021525704A/ja
Publication of JPWO2019222764A5 publication Critical patent/JPWO2019222764A5/ja
Publication of JP2021525704A5 publication Critical patent/JP2021525704A5/ja
Priority to JP2024109855A priority Critical patent/JP2025011059A/ja
Application granted granted Critical
Publication of JP7519909B2 publication Critical patent/JP7519909B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020563751A 2018-05-16 2019-05-23 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス Active JP7519909B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024109855A JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862672384P 2018-05-16 2018-05-16
PCT/US2019/033727 WO2019222764A1 (en) 2018-05-16 2019-05-23 Compositions comprising pgi2-receptor agonists and processes for the preparation thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024109855A Division JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Publications (4)

Publication Number Publication Date
JP2021525704A JP2021525704A (ja) 2021-09-27
JPWO2019222764A5 JPWO2019222764A5 (https=) 2022-05-27
JP2021525704A5 true JP2021525704A5 (https=) 2022-05-27
JP7519909B2 JP7519909B2 (ja) 2024-07-22

Family

ID=67660444

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020563751A Active JP7519909B2 (ja) 2018-05-16 2019-05-23 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス
JP2024109855A Pending JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024109855A Pending JP2025011059A (ja) 2018-05-16 2024-07-08 Ｐｇｉ２－受容体アゴニストを含む組成物、およびその調製のためのプロセス

Country Status (5)

Country Link
US (2) US12433865B2 (https=)
EP (1) EP3796902A1 (https=)
JP (2) JP7519909B2 (https=)
KR (1) KR20210040837A (https=)
WO (1) WO2019222764A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3977985B1 (en) 2017-03-01 2023-09-06 Arena Pharmaceuticals, Inc. Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
US12098116B2 (en) 2022-02-15 2024-09-24 United Therapeutics Corporation Crystalline prostacyclin (IP) receptor agonist and uses thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945530A1 (de) 1979-11-10 1981-06-04 Chemische Werke Hüls AG, 4370 Marl Harnstoffe mit cyclischen substituenten, ihre herstellung und verwendung als herbizide
JPH03160438A (ja) 1989-11-20 1991-07-10 Konica Corp ハロゲン化銀カラー写真感光材料
EP0442448A3 (en) 1990-02-13 1992-08-12 Bristol-Myers Squibb Company Heterocyclic carboxylic acids and esters
CA2085844A1 (en) 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
JPH06329598A (ja) 1993-05-19 1994-11-29 Daicel Chem Ind Ltd エステルの製造方法
GT199800126A (es) 1997-08-29 2000-01-29 Terapia de combinacion.
JPH11269138A (ja) 1998-03-20 1999-10-05 Mitsubishi Paper Mills Ltd 有機塩基発生剤
EP1046631A1 (en) 1999-04-19 2000-10-25 Rolic AG Liquid crystalline compounds
GB9908934D0 (en) 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
US20040048844A1 (en) 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
WO2002055484A1 (en) 2001-01-12 2002-07-18 Takeda Chemical Industries, Ltd. Biaryl compound, process for producing the same, and agent
WO2003007888A2 (en) 2001-07-20 2003-01-30 Adipogenix, Inc. Fat accumulation-modulating compounds
MXPA04001253A (es) 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
US7086532B2 (en) 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
TWI293715B (en) 2002-10-10 2008-02-21 Sipix Imaging Inc A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display
CN101723891A (zh) 2003-02-10 2010-06-09 沃泰克斯药物股份有限公司 通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法
JP4402413B2 (ja) 2003-09-29 2010-01-20 財団法人２１あおもり産業総合支援センター Ｕ字型化合物およびこれを含む液晶組成物
DE102004006785A1 (de) 2004-02-11 2005-09-08 Mayr, Herbert, Prof. Dr. Verfahren zur CC-Bindungsknüpfung zwischen elektrophilen Substraten und TT-Verbindungen in neutralen bis basischen wässrigen oder alkoholischen Lösungsmitteln ohne den Einsatz einer Lewis- oder Protonensäure
US20060063930A1 (en) 2004-08-20 2006-03-23 Agoston Gregory E Compositions and methods comprising proteinase activated receptor antagonists
JP2006083085A (ja) 2004-09-15 2006-03-30 Kyowa Hakko Kogyo Co Ltd 二環性ピリミジン誘導体の製造法およびその合成中間体
JP4792731B2 (ja) 2004-11-12 2011-10-12 Ｄｉｃ株式会社 重合性液晶組成物及び当該組成物の硬化物
WO2007051255A1 (en) 2005-11-04 2007-05-10 The University Of Sydney Process for the preparation of compounds containing an azacyclic ring system
JP2007161867A (ja) 2005-12-14 2007-06-28 Toyo Ink Mfg Co Ltd インキ組成物
CN101489544A (zh) 2006-05-09 2009-07-22 海玛奎斯特医药公司 治疗血液病的方法
US20110086916A1 (en) 2007-09-12 2011-04-14 Merz Pharma Gmbh & Co. Kgaa Interval therapy for the treatment of tinnitus
KR20230085944A (ko) 2008-03-18 2023-06-14 아레나 파마슈티칼스, 인크. 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제
JP5603343B2 (ja) 2008-11-26 2014-10-08 アリーナ ファーマシューティカルズ， インコーポレイテッド 関連する障害を処置するために有用なプロスタサイクリン（ｐｇｉ２）受容体モジュレーターとしてのピラゾリル置換炭酸誘導体
PT2370413E (pt) 2008-12-08 2015-10-23 Arena Pharm Inc Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo
EP2480526A1 (en) 2009-09-23 2012-08-01 Arena Pharmaceuticals, Inc. Crystalline forms and processes for the preparation of pgi2 receptor agonists
WO2016065103A1 (en) 2014-10-23 2016-04-28 Arena Pharmaceuticals, Inc. Method of treating conditions related to the pgi2 receptor
KR20260020212A (ko) * 2016-11-10 2026-02-10 아레나 파마슈티칼스, 인크. 라리네팍 및 다른 제제의 조합에 의한 pah의 치료 방법
EP3977985B1 (en) 2017-03-01 2023-09-06 Arena Pharmaceuticals, Inc. Compositions comprising pgi2-receptor agonists and processes for the preparation thereof

Similar Documents

Publication Publication Date Title
US6544556B1 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US20100221336A1 (en) Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
ES2525648T3 (es) Formulaciones galénicas que comprenden Aliskiren
JP2020510660A5 (https=)
JP2019137703A5 (https=)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
RU2011150228A (ru) Системы пленочного покрытия для препаратов с немедленным высвобождением, создающие усиленный барьер от влаги, и субстраты с таким покрытием
EP2205279B1 (en) Pharmaceutical combination of aliskiren and valsartan
JP2016534153A5 (https=)
JP2015510916A5 (https=)
JP2015524472A5 (https=)
WO2012144463A1 (ja) 腫瘍治療剤
JP2010526840A5 (https=)
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
JP2021525704A5 (https=)
RU2015138443A (ru) Способы лечения ангионевротического отека, опосредованного рецепторами брадикинина в2
JP2016514141A5 (https=)
MX2022009032A (es) Metodo de tratamiento de afecciones relacionadas con el receptor pgi2.
CA2991156A1 (en) Compositions and methods for the treatment of viral infection
CR20210043A (es) Forma de dosificación farmacèutica administrable por vía oral con liberación modificada
JP2018516266A5 (https=)
CN101801355A (zh) 包含一种或多种hmg-coa还原酶抑制剂的稳定药物组合物
EP3157520B1 (en) Apremilast for the treatment of a liver disease or a liver function abnormality
JP2013544794A5 (https=)
WO2017155053A1 (ja) 非アルコール性脂肪性肝疾患／非アルコール性脂肪性肝炎の治療剤